Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.

Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.

Item
http://www.wikidata.org/entity/Q38169633
Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia.Pharmacogenetics of childhood acute lymphoblastic leukemia.Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations.Does genetic susceptibility increase risk for neurocognitive decline among patients with acute lymphoblastic leukemia?An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001.
P2860

Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.

Item
http://www.wikidata.org/entity/Q38169633
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacogenomics of acute lymp ...... eatment toxicity and efficacy.
@en
type
label
Pharmacogenomics of acute lymp ...... eatment toxicity and efficacy.
@en
prefLabel
Pharmacogenomics of acute lymp ...... eatment toxicity and efficacy.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Pharmacogenomics of acute lymp ...... eatment toxicity and efficacy.
@en
P2093
P304
P31
P356
10.1182/ASHEDUCATION-2013.1.126
P478
P50
P577
P5875
P698
P921